References
Bruno MA, Cuello AC (2006) Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade. Proc Natl Acad Sci USA 103(17):6735–6740
Cuello AC (2001) The history of neuroscience in autobiography. In: Squire LR (ed) Society for neuroscience, vol 3. Academic Press, New York, pp 168–213
Cuello AC (2017) Early and late CNS inflammation in Alzheimer's disease: two extremes of a continuum? Trends Pharmacol Sci 38(11):956–966
Cuello AC (2019) Mi inesperada aventura en las neurociencias, siguiendo la ruta menos transitada. AAPC Asociacion Argentina Para El Progreso de Las Ciencias Tomo 7 No 1 (Ciencia E Investigacion—RESEÑAS), pp 47–70
Cuello AC, Youdim M (2015) Theodore Lionel Sourkes obituary. Mov Disord 30(4):446–447
Cuello AC, Hiley R, Iversen LL (1973a) Use of catechol O-methyltransferase for the enzyme radiochemical assay of dopamine. J Neurochem 21(5):1337–1340
Cuello AC, Horn AS, Mackay AV, Iversen LL (1973b) Letter: catecholamines in the median eminence: new evidence for a major noradrenergic input. Nature 243(5408):465–467
Cuello AC, Hall H, Do Carmo S (2019a) Experimental pharmacology in transgenic rodent models of Alzheimer's disease. Front Pharmacol 10:189
Cuello AC, Pentz R, Hall H (2019b) The brain NGF metabolic pathway in health and in Alzheimer's pathology. Front Neurosci 13:62
Do Carmo S, Hanzel CE, Jacobs ML, Machnes Z, Iulita MF, Yang J, Yu L, Ducatenzeiler A, Danik M, Breuillaud LS, Bennett DA, Szyf M, Cuello AC (2016) Rescue of early bace-1 and global DNA demethylation by S-adenosylmethionine reduces amyloid pathology and improves cognition in an Alzheimer's model. Sci Rep 6:34051
Geffen LB, Jessell TM, Cuello AC, Iversen LL (1976) Release of dopamine from dendrites in rat substantia nigra. Nature 260:258
Hall H, Iulita MF, Gubert P, Flores Aguilar L, Ducatenzeiler A, Fisher A, Cuello AC (2018) AF710B, an M1/sigma-1 receptor agonist with long-lasting disease-modifying properties in a transgenic rat model of Alzheimer's disease. Alzheimers Dement 14(6):811–823
Iulita MF, Cuello AC (2014) Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome. Trends Pharmacol Sci 35(7):338–348
Iulita MF, Ower A, Barone C, Pentz R, Gubert P, Romano C, Cantarella RA, Elia F, Buono S, Recupero M, Romano C, Castellano S, Bosco P, Di Nuovo S, Drago F, Caraci F, Cuello AC (2016) An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: relation to cognitive decline and longitudinal evaluation. Alzheimers Dement 12(11):1132–1148
Marks LV (2015) The lock and key of medicine: monoclonal antibodies and the transformation of healthcare. Yale University Press, New York
Pimentel LS, Allard S, Do Carmo S, Weinreb O, Danik M, Hanzel CE, Youdim MB, Cuello AC (2015) The multi-target drug M30 shows pro-cognitive and anti-inflammatory effects in a rat model of Alzheimer's disease. J Alzheimers Dis 47(2):373–383
Rogers J (2018) Principles for central nervous system inflammation research: a call for a consortium approach. Alzheimers Dement 14(11):1553–1559
Wilson EN, Do Carmo S, Iulita MF, Hall H, Ducatenzeiler A, Marks AR, Allard S, Jia DT, Windheim J, Cuello AC (2017) BACE1 inhibition by microdose lithium formulation NP03 rescues memory loss and early stage amyloid neuropathology. Transl Psychiatry 7(8):e1190
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cuello, A.C. Ted Sourkes, Moussa Youdim and I. J Neural Transm 127, 119–123 (2020). https://doi.org/10.1007/s00702-019-02135-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-019-02135-4